Abstract: S4-18 EFFECTS OF SIMVASTATIN ON MARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND APOPTOSIS IN CHRONIC HEMODIALYSIS PATIENTS

MLA

Kirmizis, D., et al. “Abstract: S4-18 EFFECTS OF SIMVASTATIN ON MARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND APOPTOSIS IN CHRONIC HEMODIALYSIS PATIENTS.” Atherosclerosis (Supplements), vol. 10, no. 2, June 2009, p. e1550. EBSCOhost, https://doi.org/10.1016/S1567-5688(09)71502-8.

APA

Kirmizis, D., Papagianni, A., Belechri, A.-M., Efstratiadis, G., Alexopoulos, E., & Memmos, D. (2009). Abstract: S4-18 EFFECTS OF SIMVASTATIN ON MARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND APOPTOSIS IN CHRONIC HEMODIALYSIS PATIENTS. Atherosclerosis (Supplements), 10(2), e1550. https://doi.org/10.1016/S1567-5688(09)71502-8

Chicago

Kirmizis, D, A Papagianni, A-M Belechri, G Efstratiadis, E Alexopoulos, and D Memmos. 2009. “Abstract: S4-18 EFFECTS OF SIMVASTATIN ON MARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND APOPTOSIS IN CHRONIC HEMODIALYSIS PATIENTS.” Atherosclerosis (Supplements) 10 (2): e1550. doi:10.1016/S1567-5688(09)71502-8.